Humana downgraded to Sell from Neutral at Citigroup Citigroup downgraded Humana to Sell citing the stock's 7.5% rally since the 2015 Medicare rate announcement. Citi expects a difficult Medicare rate environment in 2015 and sees risk in the company's 2014 strategy that it says favors membership over margin. The firm keeps a $95 price target for the stock.
News For HUM From The Last 14 Days
Check below for free stories on HUM the last two weeks.
Humana announces $2B share repurchase authorization Humana announced that its board has approved a $2B share repurchase authorization with an expiration date of December 31, 2016, replacing its previous $1B share repurchase authorization.